Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection

PHASE3CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

July 10, 2024

Study Completion Date

July 10, 2024

Conditions
Pancreatic Cancer
Interventions
DRUG

Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml

Patient will have their epidural started at the beginning of the surgery and receive fewer opioid drugs. The epidural is continued into the recovery room.

DRUG

Propofol+ Rocuronium+ Fentanyl + Inhalational

Patient will have the standard intraoperative management during surgery and have the epidural started just before being taken to the recovery room.

PROCEDURE

Open Pancreaticoduodenectomy

Whipple' Procedure

Trial Locations (3)

10065

Memorial Sloan Kettering Cancer Center, New York

11725

Memorial Sloan Kettering Commack (Consent only), Commack

07920

Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03434678 - Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection | Biotech Hunter | Biotech Hunter